June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Effects of Mineralocorticoid Receptor Antagonist on Diabetic Retina Using Goto-Kakizaki Rat
Author Affiliations & Notes
  • Min Zhao
    Team 17, Inserm UMRS1138, Centre de Recherche des Cordeliers, Paris, France
    University Paris Descartes, Sorbonne Paris Cité, UMRS 1138, Paris, France
  • Charlotte Andrieu-Soler
    Team 17, Inserm UMRS1138, Centre de Recherche des Cordeliers, Paris, France
    University Paris Descartes, Sorbonne Paris Cité, UMRS 1138, Paris, France
  • elodie bousquet
    Team 17, Inserm UMRS1138, Centre de Recherche des Cordeliers, Paris, France
    Department of Ophthalmology, AP-HP, Hôtel-Dieu of Paris, Paris, France
  • Rinath Levy
    Team 17, Inserm UMRS1138, Centre de Recherche des Cordeliers, Paris, France
    University Paris Descartes, Sorbonne Paris Cité, UMRS 1138, Paris, France
  • Francisco Halili
    Ophthalmic Biophysics Center, Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL
  • Alejandro Arboleda
    Ophthalmic Biophysics Center, Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL
  • Esther Rodríguez-Villagra
    Department of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, Complutense University of Madrid, Madrid, Spain
  • Irene Bravo-Osuna
    Department of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, Complutense University of Madrid, Madrid, Spain
  • Rocio Herrero-Vanrell
    Department of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, Complutense University of Madrid, Madrid, Spain
  • Francine F Behar-Cohen
    Team 17, Inserm UMRS1138, Centre de Recherche des Cordeliers, Paris, France
    Hôpital Ophtalmique Jules-Gonin, Lausanne, Switzerland
  • Footnotes
    Commercial Relationships Min Zhao, None; Charlotte Andrieu-Soler, None; elodie bousquet, None; Rinath Levy, None; Francisco Halili, None; Alejandro Arboleda, None; Esther Rodríguez-Villagra, None; Irene Bravo-Osuna, None; Rocio Herrero-Vanrell, None; Francine Behar-Cohen, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 2271. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Min Zhao, Charlotte Andrieu-Soler, elodie bousquet, Rinath Levy, Francisco Halili, Alejandro Arboleda, Esther Rodríguez-Villagra, Irene Bravo-Osuna, Rocio Herrero-Vanrell, Francine F Behar-Cohen; Effects of Mineralocorticoid Receptor Antagonist on Diabetic Retina Using Goto-Kakizaki Rat. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):2271.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Diabetic macular edema (DME) is the leading cause of blindness in the diabetic population. However, its mechanism is not fully understood. We previously showed that, in the normal rat eye, activation of mineralocorticoid receptor (MR) deregulates retinal water/ion channels, leading to retinal swelling. In diabetic patients, MR antagonism improves insulin sensitivity and reduces albuminuria. We aimed to investigate the effects of MR antagonist in diabetic retina using Goto-Kakizaki (GK) type 2 diabetic rat.

Methods: Spironolactone was loaded in poly(lactide-co-glycolide) (PLGA, lactide:glycolide 50:50) microspheres. Three-month old diabetic GK rats and age-matched control Wistar rats were used. Non-loaded or spironolactone-loaded microspheres were injected intravitreously (IVT) in the rat eye. Glycemia and glycated hemoglobin (HbA1c) were measured before and 1 month after IVT. At 1 month, animals were sacrificed, eyes removed for histological analysis. Expression of MR, water/ion channels, inflammatory markers, and angiogenic factors was also assessed in the neuroretina using quantitative PCR.

Results: The PLGA microspheres allowed sustained release of spironolactone for 1 month. Glycemia and HbA1c were more elevated in GK than in Wistar rats. Intravitreous spironolactone had no effect on glycemia or HbA1c level. GK rats showed choroidal vasodilation that was reduced by spironolactone. We observed an up-regulation of MR, AQP9, cyclooxygenase 2, interleukin 18 (IL18), neutrophil gelatinase-associated lipocalin (Ngal) and placental growth factor (PGF) in GK rats compared to Wistar rats. Among those, spironolactone significantly reduced the expression of Ngal, IL18 and PGF in GK rats.

Conclusions: GK diabetic rat shows altered retinal morphology and over-expression of MR, water channels, pro-inflammatory markers and angiogenic factors. MR antagonist reduces Ngal, IL18 and PGF transcripts and improves the retinal morphology, suggesting a MR role in the diabetic retina. The therapeutic potential of MR antagonist for diabetic retinopathy is worth further investigation.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×